Title : Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B.

Pub. Date : 2020 Sep

PMID : 32958685






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We previously showed that the fusion of the serine protease granzyme B (GrB), the effector molecule or T and B cells, to a binding domain allows the controlled and effective delivery of the cytotoxic payload into the target cell. Serine granzyme B Mus musculus
2 We previously showed that the fusion of the serine protease granzyme B (GrB), the effector molecule or T and B cells, to a binding domain allows the controlled and effective delivery of the cytotoxic payload into the target cell. Serine granzyme B Mus musculus